AstraZeneca’s Saphnelo (anifrolumab) has received a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) for approval in the European Union as a self-administered, ...

The evolution of immunotherapy, featuring CAR-T cells and senolytics, highlights potential in cancer treatment and challenges ...

AstraZeneca has announced that Saphnelo (anifrolumab) has been recommended for approval in the European Union (EU) as a ...

Lung cancer and melanoma patients immunized with this formula doubled their chances of surviving three years, according to a ...

Discover a study on oral povorcitinib for vitiligo, showing significant repigmentation and safety in patients with extensive ...

An overactive thyroid, aka hyperthyroidism, causes symptoms like fatigue and menstrual changes and can be dangerous to your ...

The drugmaker has launched an international Phase I trial, dubbed Breakfree-2, in seven countries to test the autologous therapy.

Millions of Americans take antidepressants. And like all medication they come with side effects. Researchers studied 30 ...

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

In the study, published Tuesday in the journal The Lancet, researchers analyzed more than 58,000 participants to compare 30 ...

Antidepressants can be very effective, but they also come with side effects that vary from one drug to the next, supporting ...